Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.317 GBX | +1.58% | -10.99% | -24.92% |
Jan. 31 | Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive Director | CI |
Jan. 22 | Eden Research annual revenue to beat market consensus amid sales boost | AN |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 25.9 | 18.65 | 43.74 | 28.91 | 18.09 | 22.67 | 22.67 |
Enterprise Value (EV) 1 | 25.9 | 18.15 | 43.74 | 25.47 | 18.09 | 14.87 | 18.97 |
P/E ratio | - | -16.7 x | -17.4 x | -10.4 x | -8.05 x | -2.36 x | -15.2 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 9.34 x | 9.1 x | - | 23.5 x | 9.9 x | 8.2 x | 4.51 x |
EV / Revenue | 9.34 x | 8.86 x | - | 20.7 x | 9.9 x | 5.38 x | 3.77 x |
EV / EBITDA | - | -27.8 x | - | -11.9 x | -9.43 x | -7.82 x | -31.6 x |
EV / FCF | - | - | - | - | - | -6.76 x | -4.74 x |
FCF Yield | - | - | - | - | - | -14.8% | -21.1% |
Price to Book | - | - | - | - | - | 1.93 x | 2.13 x |
Nbr of stocks (in thousands) | 207,189 | 207,189 | 380,340 | 380,340 | 380,859 | 533,353 | 533,353 |
Reference price 2 | 0.1250 | 0.0900 | 0.1150 | 0.0760 | 0.0475 | 0.0425 | 0.0425 |
Announcement Date | 4/2/19 | 5/7/20 | 6/30/21 | 5/31/22 | 5/5/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales 1 | 2.774 | 2.048 | - | 1.229 | 1.827 | 2.765 | 5.026 |
EBITDA 1 | - | -0.6516 | - | -2.133 | -1.919 | -1.9 | -0.6 |
EBIT 1 | - | -1.358 | - | -3.208 | -2.567 | -2.89 | -1.675 |
Operating Margin | - | -66.29% | - | -261.14% | -140.49% | -104.52% | -33.33% |
Earnings before Tax (EBT) 1 | - | -1.479 | - | -3.396 | -2.568 | -7.855 | -1.672 |
Net income 1 | - | -1.145 | -2.27 | -2.789 | -2.237 | -7.485 | -1.462 |
Net margin | - | -55.89% | - | -227.01% | -122.44% | -270.71% | -29.09% |
EPS 2 | - | -0.005400 | -0.006600 | -0.007300 | -0.005900 | -0.0180 | -0.002800 |
Free Cash Flow 1 | - | - | - | - | - | -2.2 | -4 |
FCF margin | - | - | - | - | - | -79.57% | -79.59% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/2/19 | 5/7/20 | 6/30/21 | 5/31/22 | 5/5/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 S1 | 2023 S2 |
---|---|---|
Net sales | - | - |
EBITDA | - | - |
EBIT | - | - |
Operating Margin | - | - |
Earnings before Tax (EBT) | - | - |
Net income 1 | -5.887 | -1.602 |
Net margin | - | - |
EPS | -0.0154 | - |
Dividend per Share | - | - |
Announcement Date | 9/29/23 | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | 0.5 | - | 3.43 | - | 7.8 | 3.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | - | - | -2.2 | -4 |
ROE (net income / shareholders' equity) | - | - | - | - | - | -21.6% | -13.9% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | - | - | 0.0200 | 0.0200 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 0.84 | - | 1.73 | - | 1.6 | 4.2 |
Capex / Sales | - | 40.81% | - | 140.5% | - | 57.87% | 83.57% |
Announcement Date | 4/2/19 | 5/7/20 | 6/30/21 | 5/31/22 | 5/5/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.92% | 28.23M | |
+14.61% | 38.38B | |
-.--% | 11.15B | |
-7.28% | 7.3B | |
+6.65% | 6.87B | |
-3.91% | 5.91B | |
-10.03% | 5.6B | |
-5.53% | 5.54B | |
+31.35% | 5.19B | |
-13.88% | 4.58B |
- Stock Market
- Equities
- EDEN Stock
- Financials Eden Research plc